FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) to update the product labeling, as filed by Baxter Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• NEXTERONE (AMIODARONE HYDROCHLORIDE)

Snippet

SUPPL AP for NEXTERONE (AMIODARONE HYDROCHLORIDE)